| Dr Neetu Godhwani, MD | |
|
107 Newtown Rd Ste 1b, Danbury, CT 06810-4151 | |
| (203) 748-7433 | |
| (203) 790-5324 |
| Full Name | Dr Neetu Godhwani |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 13 Years |
| Location | 107 Newtown Rd Ste 1b, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235530155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 56612 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Specialty Care, P.c. | 2567353121 | 21 |
News Archive
Women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women with high calcium intakes have lower risks of colorectal cancer and other cancers of the digestive system, according to a report in the February 23 issue of Archives of Internal Medicine.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
"The Internal Revenue Service won't audit you to make sure you have purchased health insurance under provisions of the new health-care law—but it may withhold your tax refund if you can't demonstrate that you are insured, an IRS official said Thursday," The Wall Street Journal reports. "There are tools we can use. We obviously will be notifying folks [for whom there is no record of health insurance] that we have these questions," Steven T. Miller, IRS deputy commissioner for services and enforcement, said.
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place.
Differences among House G.O.P. lawmakers are a key factor in this ongoing Capitol Hill drama, as some members continue to push to advance ways to delay and and derail parts of the health law. The current proposal emerging from the Senate includes changes to the overhaul but most say these provisions would not not significantly alter the measure.
› Verified 6 days ago
| Entity Name | Advanced Specialty Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053340943 PECOS PAC ID: 2567353121 Enrollment ID: O20040323000757 |
News Archive
Women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women with high calcium intakes have lower risks of colorectal cancer and other cancers of the digestive system, according to a report in the February 23 issue of Archives of Internal Medicine.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
"The Internal Revenue Service won't audit you to make sure you have purchased health insurance under provisions of the new health-care law—but it may withhold your tax refund if you can't demonstrate that you are insured, an IRS official said Thursday," The Wall Street Journal reports. "There are tools we can use. We obviously will be notifying folks [for whom there is no record of health insurance] that we have these questions," Steven T. Miller, IRS deputy commissioner for services and enforcement, said.
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place.
Differences among House G.O.P. lawmakers are a key factor in this ongoing Capitol Hill drama, as some members continue to push to advance ways to delay and and derail parts of the health law. The current proposal emerging from the Senate includes changes to the overhaul but most say these provisions would not not significantly alter the measure.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neetu Godhwani, MD 107 Newtown Rd Ste 1b, Danbury, CT 06810-4151 Ph: (203) 748-7433 | Dr Neetu Godhwani, MD 107 Newtown Rd Ste 1b, Danbury, CT 06810-4151 Ph: (203) 748-7433 |
News Archive
Women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women with high calcium intakes have lower risks of colorectal cancer and other cancers of the digestive system, according to a report in the February 23 issue of Archives of Internal Medicine.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
"The Internal Revenue Service won't audit you to make sure you have purchased health insurance under provisions of the new health-care law—but it may withhold your tax refund if you can't demonstrate that you are insured, an IRS official said Thursday," The Wall Street Journal reports. "There are tools we can use. We obviously will be notifying folks [for whom there is no record of health insurance] that we have these questions," Steven T. Miller, IRS deputy commissioner for services and enforcement, said.
An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place.
Differences among House G.O.P. lawmakers are a key factor in this ongoing Capitol Hill drama, as some members continue to push to advance ways to delay and and derail parts of the health law. The current proposal emerging from the Senate includes changes to the overhaul but most say these provisions would not not significantly alter the measure.
› Verified 6 days ago
Jane Veronica Petroff, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 57 North St Ste 216, Danbury, CT 06810 Phone: 203-797-9209 Fax: 203-748-7692 | |
Dr. Yogen Dave, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 107 Newtown Rd, Danbury, CT 06810 Phone: 203-748-7433 |